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ABSTRACT
Primordial germ cells (PGCs) are the embryonic precur-
sors of gametes in the adult organism, and their develop-
ment, differentiation, and survival are regulated by a
combination of growth factors collectively known as the
germ cell niche. Although many candidate niche components
have been identiﬁed through studies on mouse PGCs, the
growth factor composition of the human PGC niche has not
been studied extensively. Here we report a detailed analysis
of the expression of components of the bone morphogenetic
protein (BMP) signaling apparatus in the human fetal ovary,
from postmigratory PGC proliferation to the onset of pri-
mordial follicle formation. We ﬁnd developmentally regu-
lated and reciprocal patterns of expression of BMP2 and
BMP4 and identify germ cells to be the exclusive targets of
ovarian BMP signaling. By establishing long-term cultures
of human fetal ovaries in which PGCs are retained within
their physiological niche, we ﬁnd that BMP4 negatively reg-
ulates postmigratory PGC numbers in the human fetal
ovary by promoting PGC apoptosis. Finally, we report
expression of both muscle segment homeobox (MSX)1 and
MSX2 in the human fetal ovary and reveal a selective upreg-
ulation of MSX2 expression in human fetal ovary in response
to BMP4, suggesting this gene may act as a downstream
effector of BMP-induced apoptosis in the ovary, as in other
systems. These data reveal for the ﬁrst time growth factor
regulation of human PGC development in a physiologically
relevant context and have signiﬁcant implications for the de-
velopment of cultures systems for the in vitro maturation of
germ cells, and their derivation from pluripotent stem cells.
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INTRODUCTION
Primordial germ cells (PGCs) are a transient population of
germline stem cells present only during embryonic develop-
ment and are the precursors of sperm and egg in the adult or-
ganism [1]. PGCs arise from the proximal epiblast of the
mammalian embryo [2, 3] before migrating to and colonizing
the developing gonadal ridges, during which their numbers
increase substantially by mitotic proliferation. Following sex
determination, PGCs in the nascent ovary that differentiate
into oogonia; a population of transit-amplifying cells which
are irreversibly committed to meiosis, but which ﬁrst undergo
several rounds of mitotic proliferation yielding syncitial cysts
or ‘‘nests’’ of germ cells [4]. Subsequent breakdown of these
nests releases oocytes to associate with surrounding somatic
cells to form primordial follicles [5, 6]. However, the spatio-
temporal organization of these processes differs considerably
between rodents and humans. In the mouse, postmigratory
PGC proliferation, meiotic entry and arrest, and follicle for-
mation occur in three broadly synchronized waves over a pe-
riod of around 10–12 days (embryonic day [E] 10.5 to post-
natal day [P] 2) [7]. In contrast, the same events in the
human occur over a period of months and overlap consider-
ably, such that germ cells at all stages of development are
present in the fetal ovary at later gestations [8–10].
In common with stem cells in other systems, PGCs have
the capacity to undergo self-renewal (proliferation), differen-
tiation (entry into meiosis), or programmed cell death (apo-
ptosis). Achieving an appropriate balance of these cell-fate
decisions is critical, as the oocyte population formed and
assembled into primordial follicles in utero provides the basis
for the future reproductive lifespan of the adult female
(although some aspects of this have recently been questioned
[11, 12]). PGC behavior is therefore tightly regulated by the
surrounding gonadal microenvironment; a combination of
growth factors, contacts with neighboring somatic cells, and
interactions with the extracellular matrix that collectively
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have revealed a small number of growth factors, such as
bone morphogenetic protein seven (BMP7), stromal derived
factor one (SDF-1), and stem cell factor (SCF) to be essen-
tial components of the PGC niche [13–15], much of our
understanding of its growth factor composition has been
derived from in vitro studies on isolated PGCs cultured on
feeder cells (reviewed in [16]). These ﬁndings have not
always supported results in vivo, however, suggesting
feeders may not accurately recapitulate the germ cell niche
in vivo [17–20].
Members of the BMP subgroup of the transforming
growth factor-b (TGF-b) superfamily of growth factors play
essential roles throughout mammalian gametogenesis. In
mice, the formation and proliferation of the PGC precursor
population is dependent on Bmps 2, 4, and 8b [21–24],
whereas Bmp4 has also been shown to increase migratory
PGC numbers in embryo slice cultures [25]. The role of
BMP signaling in regulating the behavior of postmigratory
PGC development is less clear: culture of fetal mouse ova-
ries with Bmp2 or Bmp4 reduced the number of meiotic
g e r mc e l l s[ 2 6 ] ,y e tB m p 4h a sa l s ob e e nr e p o r t e dt op r o -
mote the proliferation of isolated postmigratory PGCs cul-
tured on feeder layers in vitro [27]. To date, no roles for
BMPs in regulating the behavior of meiotic germ cells or in
the regulation of human germ cell development have been
ascribed.
BMPs regulate a range of developmental processes includ-
ing proliferation, differentiation, and apoptosis in a tissue-
and developmental-stage speciﬁc fashion [28]. BMPs promote
apoptosis in a diverse range of developmental settings, includ-
ing embryo cavitation [29], brain and eye development [30–
32], and digit morphogenesis [33, 34]. In many of these
instances expression of the muscle segment homeobox (MSX)
genes correlates strongly with the location of BMP-induced
apoptosis [30, 31, 35] suggesting these factors to be down-
stream effectors of BMP-induced cell death. Consistent with
this, MSX2 can itself promote apoptosis in tissues known to
undergo cell death in response to BMP signaling [36, 37] and
knockdown of MSX2 expression ablates the proapoptotic
effects of BMPs [38, 39]. Although proposed [40], a proapop-
totic function for BMP signaling during early germ cell devel-
opment has not been extensively studied, and to date, no clear
data exist regarding the expression of MSX1 and MSX2 in the
developing mammalian ovary.
Here, we report the existence and characterization of a
developmentally regulated BMP-signaling system within the
human fetal ovary and demonstrate a proapoptotic effect of
BMP treatment on human PGCs in long-term cultures of
human fetal ovaries, demonstrating for the ﬁrst time regula-
tion of human PGC fate by growth factor signaling in a physi-
ologically representative system.
MATERIALS AND METHODS
Tissue
Morphologically normal ﬁrst- and second-trimester ovaries (8–20
weeks gestation) were obtained after medical termination of preg-
nancy. Maternal consent was obtained, and the study was
approved by the Lothian Research Ethics Committee. Gestation
was determined by ultrasound scan and (for second trimester
specimens) conﬁrmed by subsequent direct measurement of foot
length. Sex of ﬁrst trimester specimens was determined by PCR
genotyping for the SRY gene [41]. Ovaries were dissected into
sterile Hank’s Balanced Salt Solution (HBSS; Invitrogen, Paisley,
U.K.) before being snap-frozen and stored at –80 C (for RNA
extraction), ﬁxed in Bouin’s solution and processed into parafﬁn
using standard methods (for immunohistochemical analysis), or
cultured as detailed below.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from human fetal ovaries using the
RNeasy Micro Kit or RNeasy Mini Kit (QIAGEN, Crawley,
U.K.) with on-column DNaseI digestion according to the manu-
facturer’s instructions. For determination of gene expression
across gestation, gonads were dissected free of mesonephric tis-
sue before RNA extraction. First strand cDNA was synthesized
using the Superscript III Reverse Transcriptase Master Mix (Invi-
trogen) as per the manufacturer’s instructions. Duplicate reactions
in which the Reverse Transcriptase enzyme was omitted were set
up as negative controls.
qRT-PCR Analysis
Quantitative RT-PCR was performed as described previously
[42]. Primer sequences are detailed in Table 1. Standard curves
for each PCR amplicon were generated by plotting Ct values
from cDNA dilutions (1:5–1:10,000) of human fetal ovary cDNA,
against log concentration, and the resulting slope used to calcu-
late gene expression in experimental samples. To permit compari-
son between samples, expression of each amplicon was calculated
relative to expression of the housekeeping gene RPL32.
Immunoﬂuorescence and Immunohistochemistry
Immunoﬂuorescence was performed as described previously [43],
using rabbit polyclonal antibodies raised against BMPR1a,
BMPR1b (gifts of Dr C. Helldin, Karolinska Institute, Sweden,
both diluted 1:1,000), and pSMAD1/5/8 (New England Biolabs,
Hitchin, U.K.; #9511, diluted 1:1,000 [ﬁrst trimester specimens]
and 1:500 [second trimester specimens)). Following PBS washes,
slides were incubated with goat anti-rabbit peroxidase secondary
antibody (Vector Laboratories, Peterborough, U.K.; 1:200 dilu-
tion), then incubated in TSA Plus Fluorescein Green (Perkin Elmer,
MA, USA; diluted 1:50) for 2 minutes at room temperature. Slides
were counterstained with propidium iodide and mounted using Per-
maFluor Mounting Medium (Beckman Coulter, High Wycombe,
Table 1. Oligonucleotide primer sequences used in qRT-PCR
Gene Forward primer (50-30) Reverse primer (50-30)
BMP2 GTTCGGCCTGAAACAGAGAC GAATCTCCGGGTTGTTTTCC
BMP4 TGAGCCTTTCCAGCAAGTTT CTTCCCCGTCTCAGGTATCA
BMP7 TGGTCATGAGCTTCGTCAAC GATCCGGAACGTCTCATTGT
SMAD1 CTACCCTCACTCTCCCACCA GCACCAGTGTTTTGGTTCCT
SMAD5 TTCTGGCTCAATCTGTCAACC GGAGCCCATCTGAGTAAGGAC
SMAD8 CTGCCCCATGTGATTTACTGT GCTGAGCTGGGGCTTATATTC
MSX1 CTCCTCAAGCTGCCAGAAGAT GCTTACGGTTCGTCTTGTGTT
MSX2 TCGGAAAATTCAGAAGATGGA GAGGAGCTGGGATGTGGTAA
RPL32 CATCTCCTTCTCGGCATCA AACCCTGTTGTCAATGCCTC
Childs, Kinnell, Collins et al. 1369
www.StemCells.comU.K.). Fluorescent images were captured using a LSM510 confocal
microscope (Carl Zeiss, Welwyn Garden City, U.K.).
Immunohistochemistry was performed as previously described
[44]. Slides were incubated in primary antibody (rabbit polyclonal
antibodies to activator protein-2 gamma [AP-2c; Santa Cruz Bio-
technology Inc., Santa Cruz, CA, http://www.scbt.com; #sc-8977],
SMAD6 [Imgenex, CA, USA; #IMG-555] and cleaved caspase
three (New England Biolabs; #9601) [all diluted 1:100 in tris buf-
fered saline [TBS] supplemented with 20% normal goat serum
[NGS] and 5% BSA, except SMAD6, diluted 1:50]) at 4 C over-
night. Primary antibodies were detected using a biotinylated goat
anti-rabbit secondary antibody (Dako, Cambridge, U.K.), diluted
1:500 in TBS/NGS/BSA, and incubated for 1 hour at room tem-
perature. Staining was visualized using streptavidin-horseradish
peroxidase (diluted 1:1,000 in TBS) followed by 3,30-diaminoben-
zidine tetrahydrochloride (DAB; Dako). Immunohistochemical
detection of phosphorylated histone H3 (phospho-H3) was per-
formed on an automated Bond Immunostaining Robot using a rabbit
polyclonal to phospho-H3 (Upstate Biotechnology, Milton Keynes,
U.K., #06-570) as the primary antibody. Images were captured using
an Olympus Provis microscope (Olympus, London, U.K.).
Culture of Fetal Ovaries
Human fetal ovary-mesonephros complexes (58–65 days gesta-
tional age) were cultured on cell culture inserts (Greiner Bio-
One, Stonehouse, U.K.) in serum free medium (aMEM þ Gluta-
MAX with 1  nonessential amino acids [Invitrogen]; 2 mM
sodium pyruvate and 3 mg/ml bovine serum albumin (BSA) Frac-
tion V [both from Sigma, Poole, U.K.]; and penicillin/streptomy-
cin/amphotericin B [Cambrex Biosciences, MD, USA]) in the
presence or absence of 100 ng/ml recombinant human BMP4
(rhBMP4; Invitrogen) for 24 hours (to determine effects on MSX
gene expression) or 10 days (to determine effects on PGC num-
ber, proliferation and apoptosis) in a humidiﬁed incubator (37 C,
5% CO2). In 10 days cultures, a complete medium change was
performed every 48 hours. After culture, tissues were either lysed
in RLT buffer for subsequent RNA extraction, or ﬁxed and proc-
essed into parafﬁn for histological assessment as detailed above.
Stereological Determination of Germ Cell number,
Proliferation, and Apoptosis
Immunohistochemistry to detect AP-2c, phospho-H3, and cleaved
caspase three was performed on adjacent serial sections as out-
lined above. Total, apoptotic and proliferating PGC numbers
were determined using a Zeiss Axio Imager A1 microscope (Carl
Zeiss) ﬁtted with a camera and automatic stage (Prior Scientiﬁc
Instruments Ltd., Cambridge, U.K.). Image Pro Plus software
4.5.1 with Stereologer Pro ﬁve software (Media Cybernetics,
Workingham, U.K.) was used for cell counts and determination
of areas. Total, proliferating and apoptotic PGC numbers were
counted using the point-counting tool, and total numbers per
ovary calculated according to the method detailed in [45]. Num-
bers of AP-2c-positive cells were determined using every ﬁfth
section, whereas phospho-H3 and cleaved caspase three counts
were determined using every 10th section.
Statistical Analysis
RT-PCR data were analyzed by ANOVA (gestational changes) or
paired t tests (experimental manipulations) using GraphPad Prism
5.0 software (GraphPad Software, CA, USA).
RESULTS
Expression of BMP Ligands Is Developmentally
Regulated in the Human Fetal Ovary
We ﬁrst investigated the expression proﬁles of BMP2, BMP4,
and BMP7. We performed quantitative RT-PCR on specimens
grouped by gestational age to broadly represent three key devel-
opmental stages in human fetal ovarian germ cell development;
8–9 weeks gestation (mitotic PGC proliferation only), 14–16
weeks gestation (formation of syncitial clusters of oogonia and
onset of meiotic germ cell differentiation), and 17–20 weeks
gestation (breakdown of syncitial clusters and assembly of pri-
mordial follicles), although considerable overlap exists at later
gestations. BMP2 expression increased signiﬁcantly with gesta-
tion, rising from 0.43% 6 0.12% of expression of the house-
keeping gene RPL32 at 8–9 weeks gestation to 3.2% 6 0.34%
at 17–20 weeks (n ¼ 5–6, p < .0001, Fig. 1A), a  7.4-fold
increase. The majority of this increase occurred between 8–9
and 14–16 weeks, with a  5.7-fold increase (p < .0001). In
contrast, we detected a signiﬁcant decrease in the expression of
transcripts encoding BMP4 with increasing gestation. BMP4
gene expression was highest at 8–9 weeks, and declined sharply
at 14–16weeks (4.3% 6 0.8% at 8–9 weeks, vs. 1.8% 6 0.2%
at 14–16weeks, n ¼ 5–6, p < .001; Fig. 1B) and remained low
at 17–20 weeks (1.9% 6 0.2%). It appears therefore that recip-
rocal changes occur in the expression of BMP2 and BMP4 con-
comitant with the onset of germ cell differentiation.
We also examined the expression of BMP7. BMP7 tran-
script levels were very low,  9,000 times lower than those
encoding BMP4. BMP7 expression decreased approximately
ﬁvefold over the period examined (4.66   10
 5 % to 1.09  
10
 5%, n ¼ 5–6) but this was not statistically signiﬁcant (not
shown). These data suggest that BMP7 may not play a signiﬁ-
cant role in human fetal germ cell development in contrast to
the situation in mice [13].
Changes in Expression of Intracellular SMADs
Parallel Changes in BMP Expression
BMP receptor-regulated (BR-)SMADs 1, 5, and 8 transduce
BMP signals from the membrane to the nucleus. We detected a
small but signiﬁcant increase in the expression of transcripts
encoding SMAD1 between 8–9 and 14–16 weeks (4.14% 6
0.30% to 5.50% 6 0.32%, p < .05; Fig. 1C), although the lev-
els did not differ signiﬁcantly between 8–9 and 17–20weeks
(4.14% 6 0.30% vs. 5.06% 6 0.40%). In contrast, we detected
a sharp decline in the expression of SMAD5, which paralleled
the fall in BMP4 expression. SMAD5 expression was signiﬁ-
cantly higher at 8–9 weeks than at 14–16 or 17–20 weeks (3.8%
6 0.6% at 8–9 weeks, vs. 1.3% 6 0.05% at 14–16 weeks and
1.2% 6 0.1% at 17–20 weeks, n ¼ 5–6, p < .001; Fig. 1D).
We were unable to detect SMAD8 expression at any gestational
stage examined. Together, these data suggest a switch in the pre-
dominantly expressed SMAD may occur coincident with the
onset of germ cell differentiation in the human fetal ovary.
Germ Cells Are the Targets of BMP Signaling
in the Human Fetal Ovary
We performed ﬂuorescent immunohistochemistry to identify
the speciﬁc cell types expressing the BMP receptors BMPR1a
(ALK3) and BMPR1b (ALK6). At 9 weeks gestation, we
detected weak diffuse staining for BMPR1a throughout the
gonad, in both germ and somatic cells (Fig. 2A). In contrast,
BMPR1b expression was clearly conﬁned to PGCs (Fig. 2D).
By 14 weeks, staining for both receptors was restricted to
germ cells, a pattern which persisted to 19 weeks gestation
(Fig. 2B, 2C, 2E, 2F). BMPR1a and BMPR1b were detectable
both in germ cells in syncitial clusters (Fig. 2B, 2E, 2F) and
at later gestations in single oocytes in the process of associat-
ing with surrounding somatic cells to form primordial follicles
(Fig. 2C). We therefore conclude that expression of these pro-
teins is restricted to germ cells, which are thus the target of
BMP signaling in the human fetal ovary.
1370 BMPs in the Human Fetal OvaryThe Subcellular Localization of Phosphorylated
SMAD1/5 Changes on Germ Cell Differentiation
To determine whether germ cells are actively receiving and
transducing BMP signals, we performed immunohistochemis-
try to detect the active, phosphorylated (p-) isoforms of
SMAD1 and SMAD5. pSMAD1/5 staining was restricted to
germ cells at all gestations (9, 14, and 19 weeks) examined (Fig.
2G–2I). At 9 weeks, pSMAD1/5 staining was detected exclu-
sively in PGC nuclei (Fig. 2G), consistent with a previous report
identifying these cells to be the targets of BMP action in the
mouse gonad at a comparable developmental stage [46]. At 14
and 19 weeks gestation, germ cells continued to stain strongly
and exclusively for pSMAD1/5, but the predominant subcellular
localization of pSMAD1/5 changed dramatically, with almost all
pSMAD1/5 staining localizing to the germ cell cytoplasm (Fig.
2H, 2I). In some germ cells, pSMAD1/5 appeared to localize
exclusively to the cytoplasm, whereas in others staining was de-
tectable in both the nucleus and cytoplasm (Fig. 2H). Germ cells
with exclusively nuclear staining were rare.
Transduction of BMP signals from the cell membrane to
the nucleus requires the association of pSMAD1/5/8 with the
common mediator SMAD4, which facilitates import of the
‘‘activated’’ SMAD complex into the nucleus. This process
can be antagonized by the action of an Inhibitory (I-)SMAD,
SMAD6, which competes with SMAD4 for binding of
pSMAD1 [47]. To determine whether SMAD6 was responsible
for the cytoplasmic localization of pSMAD1/5 in differentiating
germ cells, we performed immunohistochemstry for SMAD6
on sections of 14 week gestation human fetal ovary (Fig. 3A–
3C). Strikingly, we found SMAD6 to localize exclusively to
the cytoplasm of ovarian somatic cells interspersed within and
around clusters of immunonegative oogonia. SMAD6 therefore
does not attenuate BMP signaling in human fetal germ cells by
restricting nuclear translocation of pSMAD1/5, but may insu-
late the somatic compartment against BMP signals.
BMP4 Negatively Regulates PGC Numbers in
Long-Term Cultures of Human Fetal Ovaries
To determine the role of BMP4 in regulating human PGC de-
velopment, we cultured gonad-mesonephros complexes with
or without human recombinant Bone Morphogenetic Protein 4
(hrBMP4). Immunohistochemistry for activator protein two
gamma (AP-2c), a transcription factor expressed speciﬁcally
by human PGCs and pluripotent germ cell tumor cells [48]
revealed germ cells to be abundant in control and hrBMP4-
treated ovaries, and highlighted the presence of actively pro-
liferating germ cells within the explanted gonads (Fig. 4A,
4B). Our culture conditions therefore support both
Figure 1. Expression of genes encoding BMP ligands and SMADs is developmentally regulated during human fetal ovarian development.
Expression of genes encoding BMP ligands and downstream SMAD proteins in the human fetal ovary was analyzed by qRT-PCR across a gesta-
tional range, from postmigratory primordial germ cell (PGC) proliferation (8–9 weeks gestation), through the formation of syncitial clusters of
germ cells and onset of meiosis (14–16 weeks) to the formation of the ﬁrst primordial follicles (17–20 weeks). (A) Expression of BMP2 increased
signiﬁcantly between 8–9 and 14–16/17–20 weeks gestation, concomitant with the onset of germ cell differentiation. (B) BMP4 expression
decreased markedly over the same period (***p < .001, n ¼ 5–6). (C) Expression of SMAD1 increased slightly between 8–9 and 14–16 weeks
(*p < .05, n ¼ 5–6), but was not signiﬁcantly higher at 17–20 weeks than 8–9 weeks. (D) In contrast, SMAD5 expression declined sharply from
8–9 to 14–16 weeks (***p < .001, n ¼ 5–6), mirroring the fall in BMP4 expression. Abbreviations: BMP2, Bone morphogenetic protein two;
BMP4, Bone morphogenetic protein four.
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exogenous growth factors.
We then performed stereological assessment of serial sec-
tions to determine total germ cell number and density. Control
ovaries contained an average of 42,002 6 11,455 PGCs, a ﬁg-
ure consistent with the  50,000 germ cells reported to be
present in the human fetal ovary at a comparable develop-
mental stage in vivo [49] and conﬁrming that germ cells sur-
vive well in our culture system. The addition of hrBMP4 for
10 days had a dramatic effect on PGC number, causing a sig-
niﬁcant reduction to 18,095 6 11,116 PGCs (n ¼ 4, p ¼ .03);
a decrease in germ cell number of 57% compared with
untreated controls (Fig. 4C). Total ovarian area was reduced
slightly in the hrBMP4-treated gonads compared with untreated
controls, but this did not reach statistical signiﬁcance (not
shown). To correct for this, we calculated the germ cell den-
sity, that is, the number of PGCs per unit area. PGC density
was approximately 30% lower in hrBMP4-treated gonads
compared with untreated controls (1.30 6 0.23   10
 3 vs.
1.84 6 0.32   10
 3 cells per square micrometer, n ¼ 4, p ¼
.03; Fig. 4D). These data reveal that BMP4 negatively regu-
lates PGC numbers in the ﬁrst trimester human fetal ovary.
Figure 2. Germ cells express BMP receptors and are the exclusive targets of ovarian BMP signaling. Immunohistochemical localization of type I
BMP receptors BMPR1a (A–C) and BMPR1b (D–F) in the human fetal ovary. Expression of BMPR1a in the ﬁrst trimester (9 weeks gestation) human
fetal ovary is diffuse, with expression detectable in both germ and somatic compartments (A), but expression becomes restricted to germ cells at later
gestations (B, C: 19 weeks), with no expression detectable in stromal cell streams. Following the breakdown of syncitial clusters of germ cells, single
oocytes and those in primordial follicles continue to express BMPR1a (19 weeks, C). In contrast, BMPR1b expression is germ cell speciﬁc at all gesta-
tions examined, with intense expression detectable in PGC at 9 weeks (D) and in clusters of germ cells at 14 (E) and 19 weeks (F) gestation. (G–I):
Immunohistochemical localization of phosphorylated (p)SMAD1/5. At 9 weeks gestation, pSMAD1/5 is detectable only in the nuclei of primordial
germ cells. At 19 weeks (H), a mixture of germ cells displaying solely cytoplasmic (arrows) and cytoplasmic and nuclear (arrowheads) staining can be
detected in close proximity, whereas other clusters appear to contain germ cells with exclusively cytoplasmic staining (I). (Inset in I: negative control
omitting primary antibody). Green: (A–C)B M P R 1 a ;( D–F)B M P R 1 b ;( G–I) pSMAD1/5; red: propidium iodide. Scale bars: (A, B, D–I)5 0lm, (C)
125 lm. Abbreviations: BMPR, BMP receptor; CSs, cell streams; PFs, primordial follicles; PGCs, primordial germ cells; pSMAD, phosphoSMAD.
1372 BMPs in the Human Fetal OvaryBMP4 Promotes PGC Apoptosis, But Does Not
Impair PGC Proliferation
The reduction in PGC number and density in hrBMP4-treated
gonads could arise from a decrease in PCG proliferation,
increased PGC apoptosis, or a combination of both of these
processes. We therefore performed immunohistochemistry and
stereology using the proliferation marker phospho-H3 (Fig.
5A) on adjacent sections to those used to assess total germ
cell numbers, to determine the number and proportion of
germ cells undergoing proliferation. We detected no signiﬁ-
cant difference in the proportion of phospho-H3-positive
PGCs between control and hrBMP4-treated ovaries (12.9% 6
1.4% in controls vs. 15.0% 6 2.7% in hrBMP4-treated ova-
ries, n ¼ 4, p > .05; Fig. 5B), suggesting hrBMP4-treatment
does not affect PGC proliferation.
We then repeated this approach to determine the proportion
of apoptotic PGCs, by performing immunohistochemistry/ster-
eology for cleaved caspase three (Fig. 5C). The proportion of
caspase 3-positive PGCs was signiﬁcantly elevated in hrBMP4-
treated ovaries compared with untreated controls (6.6% 6 2.2%
vs. 2.4% 6 2.2%, n ¼ 4, p < .03; Fig. 5D), an approximately
2.8-fold increase. We therefore conclude that hrBMP4 nega-
tively regulates PGC numbers in the human fetal ovary by pro-
moting apoptosis rather than by inhibiting PGC proliferation.
A BMP-Inducible Apoptosis-Related Gene Is
Upregulated in BMP-Treated Human Fetal Ovaries
We ﬁrst determined whether MSX1 and MSX2 were expressed
in the human fetal ovary. Expression of both genes rose sig-
niﬁcantly over the gestational range examined (Fig. 6A).
MSX1 expression increased 44-fold between 8–9 and 14–16
weeks, (1.5   10
 3 6 4.8   10
 5% vs. 6.4   10
 2 6 1.3  
10
 2%o fRPL32 expression, p < .001) concomitant with the
onset of germ cell differentiation, and rose 66-fold over the
entire gestational range examined. MSX2 expression was sub-
stantially higher than that of MSX1 at all gestations examined,
and also increased signiﬁcantly over the developmental win-
dow examined although the magnitude of the increase in
expression was lower. MSX2 expression increased sixfold
over the gestational range examined (0.15% 6 0.02% at 8–9
weeks to 0.50% 6 0.05% at 14–16 weeks and 0.68 6 0.04 at
17–20 weeks, n ¼ 5–6, p < .01). Expression of both MSX1
and MSX2 therefore appears to be developmentally regulated
in the human fetal ovary, with the expression of both genes
substantially upregulated as germ cells make the transition
from mitotic proliferation to meiotic differentiation.
We next examined whether MSX genes may be involved
in the BMP-induced germ cell apoptosis detected in our cul-
tures. We cultured human fetal ovary-mesonephros complexes
in the presence or absence of BMP4, and examined the
expression of MSX1 and MSX2 by qRT-PCR after 24 hours.
BMP4 increased MSX1 expression from 0.018% 6 0.003% to
0.027% 6 0.004% (n ¼ 8; Fig. 6B), although this was not
statistically signiﬁcant. In contrast, the expression of MSX2
was signiﬁcantly increased in hrBMP4-treated ovaries com-
pared with untreated controls (0.16 6 0.02 vs. 0.10% 6
0.01%, n ¼ 8, p ¼ .05; Fig. 6C), indicating a possible role
for MSX2 in BMP-induced PGC apoptosis in the human fetal
ovary.
Figure 3. SMAD6 is expressed only in the somatic compartment of the human fetal ovary. Representative photomicrographs of a section of
human fetal ovary stained for SMAD6. (A): At low magniﬁcation, large numbers of immunonegative germ cells can be seen surrounded by a
meshwork of immunopositive somatic cells (brown staining). (B, C): High magniﬁcation photomicrographs showing immunopositive somatic
cells (brown staining) surrounding immunonegative germ cells of different sizes and developmental stages. (D): Negative control omitting pri-
mary antibody. Scale bars: (A)2 0lm, (B–D)1 0lm.
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Somatic cell-derived growth factors are key regulators of
germ cell fate at diverse developmental stages. The growth
factor composition of the human fetal germline stem cell
niche has not been extensively studied, however. In this arti-
cle, we have identiﬁed the existence of a functional and devel-
opmentally regulated BMP signaling pathway in the human fetal
ovary, identiﬁed germ cells to be the sole targets of BMP action
in this organ, and revealed a proapoptotic role for BMP4 in reg-
ulating PGC development. Although previous studies have dem-
onstrated that isolated human PGCs can be reprogrammed into
pluripotent stem cells by the action of growth factors [50, 51],
we believe this to be the ﬁrst report detailing the regulation of
human PGC development by a growth factor in a physiologi-
cally relevant (i.e., gonadal niche) context.
We have observed developmentally regulated expression
of the BMP ligands BMP2 and BMP4, with an increase in the
expression of BMP2 and a decrease in the expression of
BMP4 with increasing gestation (and increasing germ cell dif-
ferentiation). It should be noted, however, that the change is
not absolute, and by 17–20 weeks gestation, the levels of tran-
scripts encoding BMP2 and BMP4 are comparable. It is there-
fore possible that BMP2 and BMP4 have distinct roles within
the fetal ovary and further work will be needed to investigate
whether their transcriptional targets, and their SMAD utiliza-
tion, differ during ovarian development. In the mouse, Bmp2
expression is restricted to the fetal ovary following sex deter-
mination and its expression driven by Wnt(4)-signaling [52].
The increasing expression of BMP2 with ongoing ovarian dif-
ferentiation reported here may reﬂect a similar mechanism in
operation in the human fetal ovary. Mice deﬁcient in Bmp7
have reduced numbers of germ cells due to a defect in PGC
proliferation after colonization of the gonad, indicating Bmp7
to be an important component of the germ cell niche [13]. We
found the expression of BMP7 to be extremely low relative to
that of BMP2 and BMP4. Therefore, although we are unable to
state deﬁnitively that BMP7 has no functional role in regulating
human fetal germ cell development, the extremely low levels
of transcript encoding this protein suggest this to be the case.
Species-speciﬁc differences may therefore exist in the reper-
toire of BMPs expressed in the developing mammalian ovary.
BMPs form homo- and heterodimers that signal through
heteromeric complexes of type I (BMPR1a, BMPR1b and
ACTR1a, also known as ALK3, ALK6, and ALK2) and type
II BMP receptors (BMPRII). Ligand binding triggers a phos-
phorylation cascade resulting in the activation of BMP-recep-
tor regulated (BR-) SMADs 1, 5, and 8, enabling their associ-
ation with SMAD4 and subsequent nuclear import [53].
Existing data on the expression of BMP receptors and BR-
SMADs in the developing mammalian gonad is contradictory.
Pesce et al. reported expression of transcripts encoding
BmpR1a and Smad1 in both germ and somatic cells in the fe-
tal mouse gonad, but were unable to detect Smad5 in puriﬁed
PGCs [27]. Conversely, Pellegrini et al. demonstrated
BmpR1a to be expressed exclusively by PGCs and found that
only Smad5 localized to the nuclei of PGCs [46], indicating
this BR-Smad to be the predominant transducer of BMP sig-
nals in germ cells at this stage. Our ﬁndings also demonstrate
Figure 4. BMP4 negatively regulates PGC numbers in human fetal ovaries cultured in vitro. Representative photomicrographs of sections of
human fetal ovaries maintained in serum-free culture for 10 days, stained for the germ cell marker activator protein-2gamma (AP-2c), showing abun-
dant PGCs (brown staining) in both control (A) and BMP4-treated (B) cultures. Mitotic PGCs are also detectable (arrows). Stereological determina-
tion of AP-2c-positive PGC numbers reveals a signiﬁcant decrease in the number of PGCs per ovary in BMP-treated cultures compared with
controls (C; p < .04, n ¼ 4), and in the number of PGCs per square micrometer (D; p < .04, n ¼ 4), revealing negative regulation of PGC numbers
by BMPs in the human fetal ovary. Scale bars: (A, B)1 0lm. Abbreviations: BMP4, bone morphogenetic protein four; PGCs, primordial germ cells.
1374 BMPs in the Human Fetal Ovarya broad expression of BMPR1a in the ﬁrst trimester human
fetal gonad, which becomes restricted to germ cells at later
gestations, and (in contrast to an earlier publication [54])
germ cell-speciﬁc expression of BMPR1b all gestations exam-
ined. The pSMAD1/5 antibody used in these studies is unable
to discriminate between the two proteins, but our ﬁnding that
SMAD5 expression is greatest in the ﬁrst trimester around the
time of PGC proliferation, and declines subsequently, may
support the hypothesis that SMAD5 is the predominant trans-
ducer of BMP signals in undifferentiated early germ cells. It
will also be of interest to determine whether the switch from
BMP4 to BMP2 expression is related to the change in expres-
sion of SMAD1 and SMAD5. We have determined that
BMP4 does not regulate SMAD5 gene expression in the
human fetal ovary (data not shown), but differential BR-
SMAD utilization in response to different BMPs has been
reported in other systems [55, 56], including mouse spermato-
gonia [46]. Consistent with the data reported here, previous
studies have also failed to detect expression of Smad8 in the
fetal mouse gonad [27, 46], suggesting the absence of a role
for this factor in gonadal development is conserved.
A striking ﬁnding of this study is the relocalization of
phosphorylated SMAD1/5 from the nucleus in PGCs to the
cytoplasm in differentiating germ cells in syncitial clusters.
This result reveals the existence of germ cell-intrinsic mecha-
nisms that act negatively to regulate/attenuate BMP signaling
by keeping phosphorylated BR-SMADs in the cytoplasm.
This was not absolute as some germ cells showed both nu-
clear and cytoplasmic pSMAD1/5 staining. SMAD6 has been
shown to negatively regulate BMP signaling by sequestering
phosphorylated SMAD1 [47], but the restriction of SMAD6
expression to somatic cells of the fetal ovary rules this out as
a possible mechanism. BMP signaling can be antagonized by
the action of peptide growth factors, such as epidermal
growth factor (EGF), which promotes the phosphorylation of
the linker region of BR-SMADs by MAP kinases and inhibits
their translocation to the nucleus [57]. It is unclear as to
whether such a mechanism of attenuating BMP signaling
could account for the near-complete relocalization of
pSMAD1/5 from nucleus to cytoplasm in differentiating germ
cells reported here. Importing b3, a member of a protein fam-
ily implicated in the nuclear import of SMADs [58] relocal-
izes from the nucleus to cytoplasm as germ cells enter meio-
sis in the fetal mouse ovary [59], suggesting key changes may
occur in the permeability of the nuclear membrane as germ
cells differentiate. This may provide a possible explanation
for the nuclear exclusion of pSMAD1/5 in oogonia, if similar
changes occur as PGCs enter meiosis in the human fetal
ovary. Interestingly, restricted SMAD nuclear import has
recently been reported in Sertoli cells in response to activin,
Figure 5. BMP4 promotes PGC apoptosis, but does not impair PGC proliferation. (A): Representative photomicrograph of a section of human
fetal ovary cultured in the presence of BMP4 for 10 days and stained for proliferation marker phosphoHistoneH3 (brown staining). Nonproliferat-
ing germ cells are also detectable (arrowhead). (B): Stereological determination of phosphoH3-postitive PGC numbers revealed no difference in
the proportion of PGCs staining positively for phosphoHistoneH3 between control and BMP4-treated groups, indicating no effect of BMP4 on
PGC proliferation (n ¼ 4, p > .05). (C): Representative photomicrograph of cultured human fetal ovary stained for the apoptosis marker cleaved
caspase 3, showing immunopositive apoptotic PGCs (brown staining) and adjacent immunonegative PGCs (arrowhead). (D): The proportion of
PGCs positively stained for cleaved caspase three was signiﬁcantly increased in BMP4-treated cultures compared with controls (n ¼ 4, p < .03),
demonstrating a proapoptotic effect of BMP4 on PGCs in the human fetal ovary and indicating enhanced apoptosis, rather than impaired prolifer-
ation, is the cause of the reduced PGC numbers in BMP4-treated human fetal ovaries. Scale bars: (A, C)1 0lm. Abbreviations: BMP4, bone
morphogenetic protein four; PGCs, primordial germ cells.
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downstream genes can be modulated selectively in response
to growth factors with pleiotropic effects [60].
Targeted disruption of Bmp4 in mice leads to a failure of
germ lineage speciﬁcation, thus the role of Bmp4 in regulat-
ing postmigratory PGCs cannot be studied in vivo. Previous
studies have demonstrated that BMP4 can act as a mitogen
for isolated mouse PGCs cultured on feeder cell layers in
vitro [27], whereas culture of fetal mouse ovaries with BMP4
has been reported to induce a testicular-like phenotype and
reduce meiotic cell numbers [26]. Our ﬁndings indicate that
within the human fetal ovary, BMP4 negatively regulates
PGC number by promoting apoptosis, suggesting that
increased germ cell death may explain the reduction in the
number of meiotic germ cells in BMP-treated fetal mouse
ovaries reported by Ross et al. [26]. The most likely explana-
tion for these differences is that PGCs display differential
responses to growth factors when isolated and propagated on
feeder layers, compared with when they are maintained within
the gonad with the germ cell niche intact. Numerous exam-
ples of this have been described. Retinoic acid exerts potent
mitogenic effects on isolated migratory and postmigratory
mouse PGCs [61], but induces meiotic entry in germ cells
cultured within intact fetal gonads obtained from mouse
embryos at equivalent developmental stages [62, 63]. Further-
more, signaling by IL-6 family cytokines, such as LIF,
through the gp130 common cytokine receptor inhibits the
entry into meiosis [18] and promotes the survival of isolated
mouse PGCs in vitro [64], and inhibition of the receptor
impairs PGC survival [17, 19]. However, mice with homozyo-
gous deletions of the gp130 receptor display only a mild,
male-speciﬁc reduction in PGC number [20] and LIF-receptor
deﬁcient mice have a normal complement of PGCs [65].
Taken together with our ﬁnding that BMP4 promotes apopto-
sis of human PGCs rather than their proliferation or survival,
these examples strongly suggest that maintaining isolated
PGCs on feeders in vitro does not accurately recapitulate their
normal gonadal microenvironment and responses in vivo, and
supports the organ-culture approach as a method of for inves-
tigating growth factor signaling in the developing human
gonad. The ability of our culture system to recapitulate the in
vivo environment is further supported by the number and pro-
portion of proliferating germ cells in our cultures, both of
which are comparable to values determined empirically using
age-matched human fetal ovaries [49]. It is important to note,
however, that differences are likely to exist between our organ
Figure 6. Developmentally regulated and BMP-inducible expression of MSX genes in the human fetal ovary. qRT-PCR analysis of MSX1 and
MSX2 expression between 8 and 20 weeks gestation in the human fetal ovary reveals expression increases signiﬁcantly with increasing gestation,
from 8 to 9, 14 to 16, and 17 to 20 weeks gestation (A; n ¼ 5–6 per group, ***p < .001,
þþp < .01). Culture of human fetal ovary-mesonephros
complexes with BMP4 for 24 hours induced a small but statistically insigniﬁcant increase in the expression of MSX1 (B; n ¼ 8, *p > .05).
Expression of MSX2, associated with apoptosis in many developmental contexts, was signiﬁcantly increased in BMP4-treated compared with con-
trols (C; n ¼ 8, *p < .05), however, suggesting a possible role of MSX2 in BMP-induced PGC apoptosis in the human fetal ovary.
1376 BMPs in the Human Fetal Ovaryculture system and the in vivo situation; growth factors pro-
duced by neighboring tissues known to affect gonadal develop-
ment may be absent or present at reduced levels in our culture
system, and the oxygen concentration is likely to differ signiﬁ-
cantly (hypoxic in vivo compared with standard normoxic tissue
culture conditions used in this study). The latter of these may
have particular signiﬁcance, as recent studies have demonstrated
that stem cells often occupy hypoxic niches, and that O2 con-
centration exerts diverse effects on stem cell survival, self-
renewal, and differentiation (reviewed in [66]).
BMP-induced apoptosis occurs in diverse developmental
contexts and is frequently associated with the expression of
MSX2 [31, 35, 38, 39]. The data presented here demonstrate
both a proapoptotic role for BMP signaling in the regulation of
postmigratory human PGCs and reveal this to be associated
with increased MSX2 expression. As MSX2 can promote exit
from the cell cycle, it has been proposed that BMP-induced
MSX2 expression in proliferating undifferentiated cells may
result in an intracellular conﬂict between proliferation and dif-
ferentiation/quiescence that can only be resolved by apoptosis
[39], and a similar conﬂict may occur within the undifferenti-
ated, proliferating PGCs within our cultures when exposed to
BMP4. Interestingly, the substantial increases in MSX gene
expression with increasing gestation correlate with the onset of
a major wave of germ cell apoptosis which occurs as syncitial
nests of germ cells break down and primordial follicles begin
to form. It is tempting to speculate that these factors may in
some way be involved in regulating this process, either by pro-
moting germ cell death, or regulating germ cell differentiation.
The data presented here have important implications for
efforts to derive germ cells from human embryonic stem
(hES) cells. BMPs have been shown to enhance the derivation
of PGCs from human [67] and mouse [68] ES cells. At doses
equivalent to those used in this study, BMP4 has been
reported to increase the expression of pre- (OCT4, NANOG,
KIT) and post- (DAZL, VASA) migratory PGC markers in dif-
ferentiating ES cells [69]. Conversely, BMP4 treatment has
also been reported to decrease VASA expression in human ES
cells differentiated in long-term (21-day) monolayer cultures
[70]. As VASA is expressed only by differentiating germ cells
in the human fetal gonad [8], this ﬁnding suggests that BMP4
has a negative effect on the derivation of differentiated germ
cells from hES cells, consistent with the loss of postmigratory
PGCs in BMP-treated ovaries reported here. Our data suggest
that sustained exposure to BMPs throughout the differentia-
tion process could be detrimental to the survival of ES-cell
derived germ cells and limit the efﬁciency of protocols to
obtain more differentiated germ cell types.
CONCLUSION
In summary, we have identiﬁed a functional and developmen-
tally regulated BMP signaling system within the developing
human fetal ovary and identiﬁed a proapoptotic role for
BMP4 in the regulation of human postmigratory PGCs. The
differences between these data and studies on isolated mouse
PGCs underline the importance of studying germ cell devel-
opment in multiple species and of utilizing physiologically
representative systems. The data reported here extend our
understanding of the growth factor composition of the human
PGC niche and how germ cell numbers are regulated in the
human fetal ovary, and will inform strategies for the differen-
tiation of germ cells from pluripotent stem cells and improve
culture systems for the differentiation of germ cells in vitro.
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